コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 s an established downstream target promoter (tenascin-c).
2 ctor SOX4 and extracellular matrix component tenascin C.
3 ascular endothelial growth factor (VEGF) and tenascin C.
4 eractions between the aggrecan G3 domain and tenascin-C.
5 ggrecan as well as articular markers such as tenascin-C.
6 ed the presence of the target protein, human tenascin-C.
7 rite outgrowth by itself and also as part of tenascin-C.
8 ion of syndecan-4 circumvents the effects of tenascin-C.
9 extracellular matrix ligands osteopontin and tenascin-C.
10 e other alpha9beta1 ligands, osteopontin and tenascin-C.
11 een control cells and cells transfected with tenascin-C.
12 duction of brain natriuretic peptide but not tenascin-C.
13 xtracellular matrix proteins osteopontin and tenascin-C.
14 all three alternatively spliced isoforms of tenascin-C.
15 tical for neutrophil migration on VCAM-1 and tenascin-C.
16 lobulin, Rab geranylgeranyl transferase, and tenascin-C.
17 lfonate significantly inhibited induction of tenascin-C.
18 that hair cells supply at least part of the tenascin-C.
19 ding to the alternatively spliced regions of tenascin-C.
20 n AP chimera, interacts strongly with native tenascin-C.
21 N-CAM, tenascin-C, FGF-5, or both N-CAM and tenascin-C.
22 action with the proteoglycan binding site on tenascin-C.
23 oximately 12 nM) as to native or recombinant tenascin-C.
24 on of proliferating cell nuclear antigen and tenascin-C.
25 ased EMT protein markers, SMA, vimentin, and tenascin-c.
26 levels under the control of the promoter for tenascin-C.
27 egulation of anti-adhesive molecules such as tenascin-C.
28 pha9beta1-mediated adhesion and migration on tenascin-C.
29 (5.8-fold versus control, P:<0.05, n=3) and tenascin-C (7.0-fold, P:<0.02) mRNA expression by strain
32 mechanical strain on the gene expression of tenascin-C, a prominent extracellular molecule in active
35 Inhibition of syndecan-4 function suppresses tenascin-C activity and overexpression of syndecan-4 cir
37 by immunocytochemistry, the distribution of tenascin-C along neural growth pathways in the developin
39 stains in the rodent heart demonstrated that tenascin-C also colocalizes with EPCs homing to sites of
40 and media-lumen ratio and overexpression of tenascin C, an extracellular matrix glycoprotein that co
41 (EGFR) found within the EGF-like repeats of tenascin-C, an antiadhesive matrix component present dur
44 s such as SPARC, thrombospondin 1 and 2, and tenascin C and X subserve important functions in extrace
46 ronment consisting of the highly upregulated tenascin-C and chondroitin sulfate proteoglycans (CSPGs)
47 Newly characterized Ets target genes such as tenascin-C and collagen type I suggest their role in dis
48 ectin type III repeats 1-2, A, B, and 6-8 of tenascin-C and fibronectin type III repeats 1-2 and 6-8
49 ith matrices representative of transitional (tenascin-C and fibronectin) and differentiated environme
50 nts of this dynamic matrix, hyaluronic acid, tenascin-C and fibronectin, differentially direct cellul
51 ograft model of advanced human osteosarcoma, tenascin-C and its receptor integrin alpha9beta1 were de
53 hesion assays showed the interaction between tenascin-C and newborn cells to be predominantly RGD-ind
54 t binding of alpha9beta1-expressing cells to tenascin-C and osteopontin, respectively, had no effect
57 d in the developing brain: the glycoproteins tenascin-C and tenascin-R and the chondroitin sulfate pr
59 ls to extracellular matrix molecules such as tenascin-C and tenascin-R may play a crucial role in loc
60 sion proteins containing various segments of tenascin-C and tenascin-R were purified, digested with t
63 ta1- and FGF-2-induced de novo expression of tenascin-C and the downregulation of alpha3(IV) collagen
64 alpha7beta1 integrin mediates a response to tenascin-C and the first to demonstrate a functional rol
68 (N-CAM), an extracellular matrix component, tenascin-C, and a soluble growth factor, fibroblast grow
69 hed with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, fa
70 ether, these results demonstrate that N-CAM, tenascin-C, and FGF-5 are dispensable for major aspects
71 transitional matrix rich in hyaluronic acid, tenascin-C, and fibronectin controls muscle cell behavio
73 n, matrix metalloproteinases (MMPs) 2 and 9, tenascin-C, and osteopontin, revealed that MMP-9 and ten
79 tracellular matrix proteins, fibronectin and tenascin-C, and the basement membrane components, lamini
80 several MMPs, TGF-beta signaling molecules, Tenascin-C, and VEGF-A, while pro-fibrotic molecules, in
83 stem cell (HSC) mimics were modified with a tenascin-C-AR to improve the homing of HSC after an auto
85 iated by the alternatively spliced region of tenascin-C are separable events that can be independentl
86 n alpha8 beta1-fibronectin, vitronectin, and tenascin-C-are not appropriately localized to mediate al
88 valuate the contribution of the glycoprotein tenascin-c as a key mediator of smooth muscle cell growt
93 the physiologically relevant presentation of tenascin-C as hexabrachion, and suggesting an increase i
94 lts show that trimers are an intermediate of tenascin-C assembly and that Cys-64 is essential for for
95 p21 loss, elevated NF-kappaB expression and tenascin C-associated rigidity, with p-Mypt1 inactivatio
96 ted epithelial cells with alpha9 integrin, a tenascin-C-binding integrin, led to a large increase in
97 adhesion modulatory proteins, fibulin-1 and tenascin-C, both of which bind to the C-terminal heparin
98 ype mice or mice with a targeted deletion of tenascin-C by assessing cell maturation, cytokine synthe
99 ha(v)beta(3), suggesting that fibrinogen and tenascin C C-terminal domains interact with alpha(v)beta
101 Using live-cell imaging, we found softer tenascin-C-coated substrates significantly enhanced migr
102 cells preferentially migrated and colonized tenascin-C-coated trabecular bone xenografts in a novel
104 f age, there were fewer condylar superficial tenascin-C/Col1-positive cells and more numerous apoptot
105 ges in netrin 4, fibroblast growth factor 2, tenascin C, collagen 1, meprin 1-alpha, and meprin 1-bet
107 top 10 results (collagen, type III, alpha-1; tenascin C; collagen, type VI, alpha-3; thrombospondin 2
113 ons were observed only to short fragments of tenascin-C containing the third fibronectin type III rep
118 -C, and osteopontin, revealed that MMP-9 and tenascin-C demonstrated reduced expression both in vitro
122 ltured on osteo-mimetic surfaces coated with tenascin C exhibited enhanced adhesion and colony format
125 C-AR modified cells aggregated to cells in a tenascin-C expressing stem cell niche model better than
126 a correlation of IL-17+ T cell numbers with tenascin C-expressing cells and MMP-9+ eosinophils was a
127 PGE(2) and augmentation of PGI(2) attenuate tenascin-C expression and vascular smooth muscle cell pr
128 showed both retention of alpha9 integrin and tenascin-C expression at the anterior stromal-epithelial
131 Suppression of GTPase activation allows tenascin-C expression to act as a regulatory switch to r
133 nregulated both TGF-beta1- and FGF-2-induced tenascin-C expression, ROCK inhibition was found to down
140 kers, including collagen types I and III and tenascin-C, fostered statistically significant cell alig
141 ey cellular regulators, such as EGFR, HSP70, Tenascin C, Frizzled-5, Patched-1, and Delta-like 1.
142 s indicated that mechanical strain increases tenascin-C gene transcription by activating nuclear fact
145 shown previously that a particular region of tenascin-C has powerful neurite outgrowth-promoting acti
146 ssibility that growth cone interactions with tenascin-C helps to guide nerve fibers in the cochlea.
148 show dynamic spatial and temporal changes in tenascin-C, hyaluronic acid, and fibronectin ECM distrib
152 s demonstrate that mechanical strain induces tenascin-C in cardiac myocytes through a nuclear factor-
154 ted to bind to fibronectin, vitronectin, and tenascin-C in cell adhesion or neurite outgrowth assays.
155 diated induction of procollagen type III and tenascin-C in isolated cardiac fibroblasts was dependent
156 cts, interstitial deposition of collagen and tenascin-C in the remodeling myocardium was markedly red
157 ults illuminate how tumor cell deposition of tenascin-C in the tumor microenvironment promotes invasi
158 te how the extracellular matrix glycoprotein tenascin-C in the tumor microenvironment promotes invasi
161 otion of neurite outgrowth by fnD as well as tenascin-C, indicating that this peptide sequence is fun
162 SCCs exhibited increased NF-kappaB and novel tenascin C, indicative of elevated rigidity; yet despite
163 n in vivo in mice, and addition of exogenous tenascin-C induces cytokine synthesis in explant culture
164 ia of individuals with rheumatoid arthritis, tenascin-C induces synthesis of proinflammatory cytokine
169 igands, implying that the RGD site in native tenascin-C is a cryptic binding site for this integrin,
180 This demonstrates for the first time that tenascin-C is essential for postnatal cardiac angiogenic
184 peptide sequence this integrin recognizes in tenascin-C is highly homologous to the sequence recogniz
186 position of the extracellular matrix protein tenascin-C is part of the reactive stroma response, whic
189 , laminin, and nidogen, as well as the large tenascin-C isoform, fibronectin, and type I gelatin in v
190 of proangiogenic genes, such as osteopontin, tenascin C, KGF, angiopoietin, HIF-1alpha, and PDGFRbeta
194 , vimentin, discoidin domain receptor 2, and tenascin C, markers of fibroblasts and components of the
197 model and showed that unlike wild-type mice, tenascin-C-/- mice fail to vascularize cardiac allograft
203 A in metastasis was established by examining Tenascin-C null mice and transgenic mice expressing Cre
206 NS and other organs have been found in adult tenascin-C-null mice, raising the question of whether th
208 ed by expressing an integrin that recognizes tenascin-C, one of the components of glial scar tissue,
209 rat aorta to investigate the interaction of tenascin-C or its various domains with these cells using
210 association of the alpha7beta1 integrin with tenascin-C peptides containing the VFDNFVLK sequence but
211 co-localizing with the fibrillar fibronectin/tenascin-C/periostin structures that characteristically
213 utonomous signaling mechanism explaining how tenascin-C promotes cancer cell migration in the tumor m
216 as occurs in the presence of the ECM protein tenascin-C, promotes a motile phenotype; FAK and Rho sig
217 Analysis of human coronary thrombi revealed tenascin-C protein expression colocalized with the endot
218 RNA (3.9 +/- 0.5-fold, p < 0.01, n = 13) and tenascin-C protein in an amplitude-dependent manner but
221 ansgenic approach, we have demonstrated that tenascin-C regulates both cell proliferation and migrati
222 f the provisional matrix, we have found that tenascin-C regulates cell responses to a fibrin-FN matri
225 aling by competitive binding of fibulin-1 or tenascin-C represents a shared mechanism of adhesion mod
226 21-associated differentiation in wdSCCs; yet tenascin C retention in connective tissue extracellular
227 um channels on microtiter plates coated with tenascin-C revealed saturable and specific binding with
228 dorsal root ganglia regenerated through the tenascin-C-rich dorsal root entry zone into the dorsal c
230 Of these, "FD" and "FV" are conserved in tenascin-C sequences derived from all the species availa
231 ssed in the SVZ, and transgenic mice lacking tenascin C show delayed acquisition of the EGF receptor.
233 Here we show that mice that do not express tenascin-C show rapid resolution of acute joint inflamma
234 we show that the regenerative ECM component tenascin-C significantly increases newt cardiomyocyte ce
235 erexpressed the largest but not the smallest tenascin-C splice variant when given a choice between co
238 he desmoplastic extracellular matrix protein tenascin C, suppressing tumor outgrowth, and improving h
239 e utilized the extracellular matrix molecule tenascin-C (tenascin) and an antibody (Ab) to the cell a
243 taining the fibronectin type III domain D of tenascin C, the long NC3 isoform of collagen type XII, t
244 e effective than laminin-1, L1-Fc, or intact tenascin-C, thus demonstrating the potential applicabili
248 Intense matrix metalloproteinase (MMP-2) and tenascin-C (TN-C) expression were seen in the proximity
254 To address this question, we focused on tenascin-C (TN-C), a stromal extracellular matrix glycop
255 icipates in network formation, we focused on tenascin-C (TN-C), an extracellular matrix (ECM) protein
256 dy was performed to test the hypothesis that tenascin-C (TN-C), an extracellular matrix (ECM) protein
258 PDGF-BB also stimulates the expression of tenascin-C (TN-C), an extracellular matrix glycoprotein
260 ed the expression of the profibrotic factors tenascin C (TNC) and connective tissue growth factor (CT
262 catenin signaling led to marked induction of tenascin C (TNC), an established promoter of cancer meta
263 of multiple metastasis effectors, including Tenascin C (Tnc), Jagged1 (Jag1), and Epiregulin (Ereg).
264 ranscriptional regulation of the ECM protein tenascin C (Tnc), which was necessary and sufficient for
267 ctive tissue growth factor (Ctgf, P = 0.04), tenascin C (Tnc, P = 0.035), Collagen Ialpha1 (Col1a1, P
268 tified the extracellular matrix glycoprotein tenascin-C (TNC) as an important regulator of ENCC devel
269 o determine the temporospatial expression of tenascin-C (TnC) in balloon-injured rat and porcine arte
270 pattern of the extracellular matrix molecule tenascin-C (Tnc) in the developing mouse olfactory bulb
275 r mPIN used the extracellular matrix protein Tenascin-C (TNC) to inhibit T-cell receptor-dependent T-
278 ral S100 proteins, including Fibronectin and Tenascin-C (Tnc), in primary lung tumors and associated
282 th at least three members: tenascin-X (TNX), tenascin-C (TNC, or cytotactin) and tenascin-R (TN-R, or
283 ne signature identified five common targets: tenascin-C(TNC), matrix metalloprotease-2, collagen-6-A1
284 ctin (fnFN10) and the 3rd FN-III domain from tenascin-C (tnFN3) have 27% sequence identity and the sa
285 EDGIHELFP(48)) resembles the sequence within tenascin-C to which the integrin alpha(9)beta(1) binds.
286 nD to an eight amino acid sequence unique to tenascin-C, VFDNFVLK, and showed that the amino acids FD
287 ha-smooth muscle actin were reduced, whereas tenascin C was increased, suggesting that P15-1 promoted
288 sis of PAH such as serotonin transporter and tenascin-C was elevated in distal arteries and had a hig
289 Fibroblast response to fibulin-1, similar to tenascin-C, was dependent on expression of the heparan s
290 aptamer to the extracellular matrix protein tenascin-C, was prepared in fluorescent and radiolabeled
291 nction relationships of different domains of tenascin-C, we used recombinant full-length fibronectin-
292 remodeling such as MMP-9, procollagen-3, and tenascin C were observed in all acute eczematous lesions
295 pha-smooth muscle actin (SMA), vimentin, and tenascin-c, were measured in archived human HCC tissues
296 ar degeneration-affected Bruch's membrane is tenascin-C which we confirm is present at high levels in
297 ulation of the extracellular matrix protein, tenascin C, which affords a scaffold for VSMC migration.
299 nderstanding the mechanism of interaction of tenascin-C with smooth muscle cells and a framework for
300 milarity with the fibrinogen domain of human tenascin-C, with a human C-type serum lectin, and with p
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。